PRSS16 and hepatocellular carcinoma: Considering the results in TPX2high-HCC vs TPX2low-HCC groups, Table 1 elucidated a consistent finding with the expression analysis of four DElncRNAs (TRHDE-AS1, DLX6-AS1, SNHG14, HOXA11-AS), four DEmiRNAs (miR-23b, miR-320a, miR-589, miR-126) and five DEmRNAs (PKIA, PCDHA2, SHCBP1, PRSS16, KIF18A) in HCC tumor vs normal groups.